NCT07667608
- Conditions
- Adenocarcinoma, Ascites, Atrophy, +27 more
- Locations
-
Not specified
Clinical trial condition
Liver Neoplasms
Explore clinical trials studying Liver Neoplasms. Study availability and eligibility vary by location and protocol.
1,743 public trials
464 recruiting studies
Liver Neoplasms trial results
Not Yet Recruiting
SBRT Plus QL1706 as Second-Line Therapy for Hepatocellular Carcinoma
NCT07668570
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
Not specified
NCT07663487
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
Not specified
Not Yet Recruiting
Erlotinib for Hepatocellular Carcinoma Chemoprevention
NCT04172779
- Conditions
- Adenocarcinoma, Advanced Liver Fibrosis, Carcinoma, +14 more
- Locations
-
- UT Southwestern Medical Center Dallas, Texas, United States
Not Yet Recruiting
NK521 in the Treatment of Advanced Solid Tumors
NCT07657416
- Conditions
- Adenocarcinoma, Adnexal Diseases, Carcinoma, +24 more
- Locations
-
- 1st affiliated hospital of Anhui Medical University Hefei, Anhui, China
Not Yet Recruiting
Yttrium-90 Carbon Microsphere Radioembolization in Previously Treated Hepatocellular Carcinoma
NCT07657273
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- The Second Affiliated Hospital, Guangzhou Medical University Guangzhou, Guangdong, China
Not Yet Recruiting
A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors
NCT07636785
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +49 more
- Locations
-
- HonorHealth Research Institute Scottsdale, Arizona, United States
Not Yet Recruiting
CHARM Hepatocellular Carcinoma MEA Study
NCT07650773
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
Not specified
Not Yet Recruiting
Pilot Study of Intermittent Fasting With Immune Checkpoint Inhibitors
NCT07645742
- Conditions
- Adenocarcinoma, Cancer (Advanced Stage), Carcinoma, +29 more
- Locations
-
Not specified
Not Yet Recruiting
PD-1/IL-2 Bispecific Antibody as Neoadjuvant Therapy for Early Recurrent Hepatocellular Carcinoma After Curative Hepatectomy
NCT07644208
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
Not specified